Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 26 Mar 2026. The item focuses on Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion–Positive Non–Small Cell Lung Cancer. Review the original article for the full source wording and details.
Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 26 Mar 2026.
The item focuses on Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion–Positive Non–Small Cell Lung Cancer.
Review the original article for the full source wording and details.